CGI
BNTX icon

Comgest Global Investors’s BioNTech BNTX Stock Holding History

Comgest Global Investors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-187,746
Closed -$20.4M – 65
2023
Q3 		$20.4M Sell
187,746
-19,862
-10% -$2.2M 0.35% 33
2023
Q2 		$22.4M Hold
207,608
– – 0.37% 36
2023
Q1 		$25.9M Sell
207,608
-15,244
-7% -$2.09M 0.49% 26
2022
Q4 		$33.5M Sell
222,852
-3,563
-2% -$548K 0.74% 23
2022
Q3 		$30.5M Sell
226,415
-11,046
-5% -$1.69M 0.67% 25
2022
Q2 		$35.4M Sell
237,461
-20,602
-8% -$3.15M 0.7% 25
2022
Q1 		$44M Buy
258,063
+68,788
+36% +$11.6M 0.69% 25
2021
Q4 		$48.8M Buy
189,275
+7,177
+4% +$1.97M 0.65% 25
2021
Q3 		$49.7M Sell
182,098
-106,881
-37% -$34M 0.65% 25
2021
Q2 		$64.7M Buy
+288,979
New +$54.5M 0.88% 24

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Comgest Global Investors's BNTX Position: Q4 2023 in Review

Comgest Global Investors sold out of BioNTech (BNTX) in Q4 2023, closing a stake of 187,746 shares — an estimated $20.4M sold.

Comgest Global Investors first reported a position in BNTX in Q2 2021 and held it in 10 quarters. The position peaked at $64.7M in Q2 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q4 2023.

  • Comgest Global Investors reported no remaining BioNTech position as of Q4 2023 after selling out during the quarter.
  • Comgest Global Investors sold 187,746 BioNTech shares in Q4 2023, an estimated $20.4M.
  • Comgest Global Investors first reported a position in BioNTech in Q2 2021 and held it in 10 quarters.
  • Comgest Global Investors's BioNTech position peaked at $64.7M in Q2 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q4 2023.

Based on Comgest Global Investors's 13F filing for Q4 2023, filed 12 Feb 2024.